Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 1 of the last 3 fiscal years.
-
Two loss years in a row NBB
Negative result in 2022 and 2023.
-
Late annual account NBB
Fiscal year 2023 was filed 391 days after the legal deadline.
-
Busy address KBO
16 other companies have their registered office at the same address; threshold 10.
-
Legal situation KBO
Gerechtelijke ontbinding of nietigheid according to the CBE.
Financials
Financial year 2023
BIOCARTIS GROUP from Antwerpen, company number BE0505640808, closed financial year 2023 with a result of € -261.8 million after tax. For that financial year BIOCARTIS GROUP recorded revenue of € 5.1 million and equity of € -420,440. Compared with financial year 2022, the result moved from € -180.7 million to € -261.8 million. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 26, 2025.
€ -420,440
▼ € 260.8 million vs 2022
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -261.8 million
▼ 45 % more loss than in 2022
Profit after tax over the fiscal year.
€ 649,223
▼ 92% vs 2022
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -442.5 million.
People and assets in 2023
20
▼ 6.6 vs 2022
Average over the fiscal year, from the social balance sheet.
€ 2.2 million
▼ 37% vs 2022
€ 110,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2023
None
No bank loans on the last day of the fiscal year.
€ 319,014
▼ 92% vs 2022
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 50 days on average.
€ 5,338
▼ 99% vs 2022
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2023 | Change 2022 → 2023 | |
|---|---|---|---|---|
| Revenue | € 6,584,447 | € 6,420,461 | € 5,053,304 | ▼ 21% |
| Profit after taxes | € -34,132,940 | € -180,725,783 | € -261,777,064 | ▼ € 81.1 million |
| Equity | € 402,819,641 | € 260,408,948 | € -420,440 | ▼ € 260.8 million |
| Total debts | € 137,384,762 | € 130,710,222 | € 345,055 | ▼ € 130.4 million |
| Cash | € 9,665,039 | € 8,576,208 | € 649,223 | ▼ 92% |
| Retained profit | € -148,045,190 | € -180,725,783 | € -442,502,847 | ▼ € 261.8 million |
| Bank debt | € 135,000,000 | € 125,103,824 | € 0 | ▼ 100% |
| Balance sheet total | € 540,204,403 | € 391,119,170 | € 1,027,271 | ▼ € 390.1 million |
| Employees (FTE) | 25.5 | 26.6 | 20 | ▼ 6.6 |
Key figures of BIOCARTIS GROUP, fiscal years 2021 to 2023, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2024 has not been filed yet; it was expected before 31 July 2025.
What happened to BIOCARTIS GROUP?
What happened at BIOCARTIS GROUP in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
BIOCARTIS GROUP is active according to the CBE. Legal situation: Gerechtelijke ontbinding of nietigheid.
- New annual accounts for financial year 2023: loss of € 261.8 million. filed late Source: NBB ↗
- Luc Gijssens BV stepped down as director. NBB
- Ann-Christine Sundell stepped down as director. NBB
- Christine Kuslich stepped down as director. NBB
- Bryan Dechairo stepped down as director. NBB
- Bryan Dechairo became a director. NBB
- Roald Borré stepped down as director. NBB
- Christine Kuslich became a director. NBB
In short
From € 34.1 million loss in 2021 to € 261.8 million loss in 2023.
Paid € 10,505 in corporate taxes since 2021.
Pays suppliers within 50 days on average.
A new publication or filing at BIOCARTIS GROUP? We notify you, reason included.
Follow BIOCARTIS GROUPDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind BIOCARTIS GROUP are South Bay Ventures BV and Christian Reinaudo. The shares are held by Invesco Ltd. (9.8%), Federale Participatie- en Investeringsmaatschappij (7.2%), UBS Group AG (4.5%), Credit Suisse Group AG (4.3%) and Johnson & Johnson Innovation - JJDC, Inc. (4.1%). It owns 50% of Wondfo-Cartis Limited itself.
Directors
According to the 2023 annual accounts
Director · represented by Herman Verrelst
Also active at: BIOCARTIS, OPDORP FINANCE
since 2022
since 2021
Christine Kuslich
Director
since 2022 · until 2025
Bryan Dechairo
Director
since 2023 · until 2024
Director · represented by Luc Gijssens
Also active at: GLOBAL RENTAL PROPERTIES, Serax Immo, Arvesta, WBC, ALIREC, RESCOO, Five Stars Properties
since 2022 · until 2025
since 2022 · until 2023
Ann-Christine Sundell
Director
since 2022 · until 2025
Shareholders
Invesco Ltd.
9.8%
UBS Group AG
4.5%
Credit Suisse Group AG
4.3%
Johnson & Johnson Innovation - JJDC, Inc.
4.1%
Participations
Wondfo-Cartis Limited
50%
Establishments
Establishment units
Physical locations of this company
Potvlietlaan 6
2600 Antwerpen
Generaal De Wittelaan 11
2800 Mechelen
Active since 24 November 2014
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 16 companies are registered at this address.
All companies at this address →Advocatenkantoor Yannick Grauwels
€ 108,291 gross margin · 2025
Mann + Hummel Hydromation
€ -23,495 gross margin · 2025
DELTA - ALPHA
€ 1.1 million gross margin · 2025
NATHACO
€ 60,061 gross margin · 2025
LINK 26
+11 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0505.640.808
- VAT number
- BE 0505.640.808
- Registered office
- Potvlietlaan 6, 2600 Antwerpen
- Names & denominations
- BIOCARTIS GROUP
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Gerechtelijke ontbinding of nietigheid
- Start date
- 24 November 2014
- Peppol
- Active · Active since 1 Jan 2001